Insulin resistance is a risk factor for progression to type 1 diabetes.
about
Diabetes and gastric cancer: the potential linksAnti-CD38 autoantibodies in type? diabetesSkeletal muscle as a therapeutic target for delaying type 1 diabetic complicationsDiet, Microbiota and Immune System in Type 1 Diabetes Development and EvolutionThe interplay of autoimmunity and insulin resistance in type 1 diabetesThe streetlight effect in type 1 diabetesGlucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).Surrogate index for insulin sensitivity composed of factors not using glucose and insulin in Japanese patients with diabetesProgression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onsetBanting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.Prediction and pathogenesis in type 1 diabetes.Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in miceMetabolic regulation in progression to autoimmune diabetesGlucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years.Type-specific human papillomavirus detection in cervical smears in Romania.Advanced glycation end products are direct modulators of β-cell function.Insulin resistance and associated factors in patients with Type 1 Diabetes.Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at preventionThe great weight gain experiment, accelerators, and their implications for autoantibodies in diabetes.Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypesMajor increase in Type 1 diabetes: no support for the Accelerator Hypothesis.Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance.Dietary glycemic index, development of islet autoimmunity, and subsequent progression to type 1 diabetes in young children.Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes.Metabolic syndrome and autoimmune diabetes: action LADA 3.Vaccination against self to prevent autoimmune disease: the type 1 diabetes model.Helminth infection and type 1 diabetes.Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis.The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysisFollowing the fate of the failing β-cell: new insights from first-phase insulin responsesImmunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the futureThe accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Autoimmunity and the pathogenesis of type 1 diabetes.Obesity and susceptibility to autoimmune diseases.
P2860
Q24602836-99976EDB-41B1-4854-B7F0-D818E99D4FD2Q24652207-8836FD77-2B8B-4E80-8D50-E2DB6112FFF2Q26775403-0B9FBFBF-6C36-4741-89AA-17E1D808585EQ26777399-ADC27665-6966-4CAA-8A5B-FF8D90D364F2Q26823862-CF74B443-2681-4CCB-934B-9466BB97B328Q27023064-B59C2534-E65A-4B42-9638-B8B255D37883Q30505367-4EBB5A9C-D9C6-4B29-AA63-124BB926AAC2Q33588313-6F3CB42B-89E9-43A2-8F65-920A2D014308Q33688616-053AF59F-BB8B-4E67-9D9B-834A43F1B655Q33750667-1BB43BA3-DF65-49B3-8D99-2A07EE54E41DQ33818896-8FC20511-A18E-4496-B66A-C085F5E2BBC4Q33855851-2E9B1DC6-D14F-4C27-92BD-B1328145CAA7Q34064185-FC275CF0-0C91-4ED5-9D71-8F5B20230B8CQ34072322-4C3EB47B-1575-4613-A685-B47893EA9BEBQ34615329-6B78B68A-22DF-4491-B913-512451409687Q35094156-0A471D36-240E-4224-AB73-29598C0CEE2BQ35227180-CC1ACAFE-2DCF-4774-AB1D-7DF768A8FD7FQ35559139-0E15C7BD-1A17-4249-B71D-CF620B8F2114Q35612681-D119A26C-627F-4E27-A029-390CDA16E9CBQ35792511-FC328BDB-9DEE-4657-BE7F-BB69441945DBQ35976782-F78271DE-9935-49A1-A8CD-3EA9A185F27CQ36117948-1210DC2C-3F05-4885-8B30-511BBEC039D2Q36153012-2631730F-E30C-4A36-AD4F-C6DEDAE5DEDBQ36249543-E5891755-673A-494D-90BA-96221B78E2CEQ36807498-8FE9040C-D9AB-4217-97FC-346BA0A699E6Q36834380-9FF26070-3D0F-4A15-8289-3AD006DCF127Q36867481-F0FD69A3-1FCC-4A2F-80E2-CE98E20EF7ABQ36964847-DFE6EBF6-8210-4C65-BE10-77DB533D84C5Q37022908-C88FA31A-A605-432C-8547-F9FC0A42C766Q37022978-3F29DCD8-C87E-4A6C-ADB8-3598C2FE7469Q37052632-7430A6CB-2DE9-48F0-B70D-AFD45D5241A1Q37088203-23374CD6-B2E9-45DD-8A29-B8C26A19FA5AQ37186774-0F1B84DE-26A0-416E-B110-0BFA2F2E13CFQ37257559-85125065-D48D-4571-8D6E-91191D8AFFDEQ37333539-9587C7E1-BAF1-4331-9A41-72C0020F3CFAQ37364899-EE14114D-BA1E-4A44-AA88-667381BCBE7FQ37511687-E395ED57-844A-41FB-AA2B-03FFCAB75776Q37659402-BB3EFC50-314A-46DD-8D0F-7FBAF8D51694Q37764866-9CD09BCA-0F1A-4C19-BD1A-6175FD38B2DCQ37877257-B1681544-2755-4F27-AF6D-4A6DB152AB1F
P2860
Insulin resistance is a risk factor for progression to type 1 diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Insulin resistance is a risk factor for progression to type 1 diabetes.
@en
Insulin resistance is a risk factor for progression to type 1 diabetes.
@nl
type
label
Insulin resistance is a risk factor for progression to type 1 diabetes.
@en
Insulin resistance is a risk factor for progression to type 1 diabetes.
@nl
prefLabel
Insulin resistance is a risk factor for progression to type 1 diabetes.
@en
Insulin resistance is a risk factor for progression to type 1 diabetes.
@nl
P2093
P921
P1433
P1476
Insulin resistance is a risk factor for progression to type 1 diabetes.
@en
P2093
G B Byrnes
L C Harrison
P G Colman
P Narendran
S Fourlanos
P2888
P304
P356
10.1007/S00125-004-1507-3
P577
2004-10-06T00:00:00Z
P5875
P6179
1012643048